← Eichor
Condition: Ami Cardiogenic Shock Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ami Cardiogenic Shock

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intra-aortic Balloon Counterpulsation (IABC) Compliance
Phase N/A · 1 location(s) · Thomas Jefferson University · NCT07402018Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04184635CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
Phase 4 · 3 location(s) · Ottawa Heart Institute Research Corporation · NCT05267886Cardiogenic Shock Working Group Registry
Phase N/A · 16 location(s) · Tufts Medical Center · NCT04682483Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arteri
Phase 4 · 2 location(s) · Samsung Medical Center · NCT06696235Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest rece
Phase 2 · 1 location(s) · IRCCS San Raffaele · NCT06792643Ivabradine in the Acute Management of Cardiogenic Shock
Phase 3 · 1 location(s) · National Institute of Cardiovascular Diseases, Pakistan · NCT07714746On Scene ECPR in Ostrava
NA · 2 location(s) · University Hospital Ostrava · NCT07374289Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbi
Phase 3 · 28 location(s) · Pr Bruno LEVY · NCT04020263Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care
Phase 1/Phase 2 · 25 location(s) · 4TEEN4 Pharmaceuticals GmbH · NCT06832722Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
Phase N/A · 3 location(s) · STAVROS G DRAKOS · NCT05185492Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock
NA · 1 location(s) · Rigshospitalet, Denmark · NCT06638268Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Phase 2 · 5 location(s) · Stanford University · NCT06080074The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05752383Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery
Phase 4 · 1 location(s) · University of Sao Paulo · NCT06934798COMPARE-VENT Feasibility Pilot Study
NA · 1 location(s) · Mayo Clinic · NCT07656259Physiology of Unloading VA ECMO Trial
Phase 2 · 1 location(s) · University of Utah · NCT06336655Cardiac Power Output in Cardiogenic Shock Patients
EARLY_Phase 1 · 1 location(s) · University of Chicago · NCT05700617Genomic Determinants of Outcome in Cardiogenic Shock
Phase N/A · 1 location(s) · Barts & The London NHS Trust · NCT05728359The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock
NA · 1 location(s) · Bach Mai Hospital · NCT07062744Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Phase N/A · 1 location(s) · Tufts Medical Center · NCT06253104The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry
Phase N/A · 1 location(s) · University Hospital Freiburg · NCT05811780Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
Phase N/A · 4 location(s) · University Heart Center Freiburg - Bad Krozingen · NCT07515508Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
Phase 4 · 1 location(s) · Institute for Clinical and Experimental Medicine · NCT07527156Early Beta Blocker Administration in STEMI Patients With SCAI B Status
NA · 1 location(s) · Tel-Aviv Sourasky Medical Center · NCT06967194Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
NA · 4 location(s) · Ottawa Heart Institute Research Corporation · NCT05298124Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Phase N/A · 2 location(s) · Abu Dhabi Health Services Company · NCT06535503Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Phase N/A · 18 location(s) · Abiomed Inc. · NCT06964685Altshock-2 REGISTRY
Phase N/A · 1 location(s) · Niguarda Hospital · NCT04295252BEAT-SHOCK Registry
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT07643610
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.